CV Therapeutics, Inc.
🏢 View company profile →109Patents
14Active
109Granted
43Portfolio score
Filing activity: Sep 26, 1994 → Aug 27, 2007 · 14 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7160592B2 | Polymer coating for medical devices | Emerging Cross-Sectional Technologies | 125 | Expired |
| US5866702A | Purine inhibitors of cyclin dependent kinase 2 | Chemistry; Metallurgy | 102 | Expired |
| US6294522A | N6 heterocyclic 8-modified adenosine derivatives | Human Necessities | 72 | Expired |
| US6403567B1 | N-pyrazole A2A adenosine receptor agonists | Chemistry; Metallurgy | 60 | Expired |
| US6605597B1 | Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives | Human Necessities | 59 | Expired |
| US5789416A | N.sup.6 mono heterocyclic substituted adenosine derivatives | Human Necessities | 57 | Expired |
| US6075150A | .alpha.-ketoamide inhibitors of 20S proteasome | Human Necessities | 55 | Expired |
| US6214807A | C-pyrazole 2A A receptor agonists | Human Necessities | 45 | Expired |
| US6677342B2 | Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure | Human Necessities | 43 | Expired |
| US6825349B2 | A2B adenosine receptor antagonists | Chemistry; Metallurgy | 42 | Expired |
| US6781000B1 | Alpha-ketoamide inhibitors of 20S proteasome | Human Necessities | 40 | Expired |
| US6552023B2 | Aralkyl substituted piperazine compounds | Chemistry; Metallurgy | 40 | Expired |
| US6548548B2 | ABCA-1 elevating compounds | Chemistry; Metallurgy | 37 | Expired |
| US6977300B2 | A2B adenosine receptor antagonists | Chemistry; Metallurgy | 37 | Expired |
| US6642210B1 | 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists | Chemistry; Metallurgy | 33 | Expired |
| US6573264B1 | Heteroaryl alkyl piperazine derivatives | Chemistry; Metallurgy | 32 | Expired |
| US6794390B2 | Purine inhibitors of cyclin dependent kinase 2 & ikappabalpha | Chemistry; Metallurgy | 31 | Expired |
| US6599283B1 | Method of preventing reperfusion injury | Human Necessities | 31 | Expired |
| US7553823B2 | C-pyrazole A2A receptor agonists | Human Necessities | 29 | Active |
| US7144872B2 | N-pyrazole A2A receptor agonists | Chemistry; Metallurgy | 29 | Expired |
| US6677336B2 | Substituted piperazine compounds | Chemistry; Metallurgy | 29 | Expired |
| US6479496B1 | Methods for treating angina with ranolazine | Human Necessities | 28 | Expired |
| US6770634B1 | C-pyrazole a2a receptor agonists | Human Necessities | 27 | Expired |
| US6855818B2 | C-pyrazole A2A receptor agonists | Human Necessities | 26 | Expired |
| US7183264B2 | N-pyrazole A2A receptor agonists | Chemistry; Metallurgy | 25 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.